gptkbp:instanceOf
|
gptkb:person
|
gptkbp:awardReceived
|
gptkb:Chevalier_de_la_Légion_d'honneur
gptkb:American_Chemical_Society_Heroes_of_Chemistry_Award
|
gptkbp:birthPlace
|
gptkb:Alexandria,_Egypt
|
gptkbp:birthYear
|
1950
|
gptkbp:children
|
gptkb:Michael_Schinazi
gptkb:Nina_Schinazi
|
gptkbp:citizenship
|
gptkb:France
gptkb:United_States
|
gptkbp:education
|
gptkb:University_of_Bath
gptkb:University_of_North_Carolina_at_Chapel_Hill
|
gptkbp:employer
|
gptkb:Emory_University
|
gptkbp:field
|
antiviral drug research
|
gptkbp:founded
|
gptkb:Pharmasset
gptkb:RFS_Pharma
gptkb:Triangle_Pharmaceuticals
|
https://www.w3.org/2000/01/rdf-schema#label
|
Raymond F. Schinazi
|
gptkbp:knownFor
|
HIV drug development
Hepatitis C drug development
|
gptkbp:nationality
|
gptkb:American
gptkb:French
|
gptkbp:notableWork
|
Development of emtricitabine
Development of lamivudine
Development of sofosbuvir
|
gptkbp:occupation
|
gptkb:pharmacy
chemist
entrepreneur
|
gptkbp:position
|
Professor of Pediatrics
|
gptkbp:residence
|
gptkb:Atlanta,_Georgia,_USA
|
gptkbp:spouse
|
gptkb:Nathalie_Schinazi
|
gptkbp:bfsParent
|
gptkb:Pharmasset
|
gptkbp:bfsLayer
|
6
|